SCHEMBL29558387

SCHEMBL29558387

CCC(CC)c1ccn2ncc(Cl)c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNT1 O60563 2/20 0.41
▸ CDK9 P50750 2/20 0.41
▸ PIM1 P11309 1/20 0.34
▸ SMPD3 Q9NY59 2/20 0.33
▸ IRAK4 Q9NWZ3 2/20 0.33
▸ CHRNA7 P36544 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ PDE2A O00408 1/20 0.31
▸ CDK1 P06493 1/20 0.30
▸ CDK4 P11802 1/20 0.30
▸ CCNA2 P20248 1/20 0.30
▸ CCND1 P24385 1/20 0.30
▸ CCNC P24863 1/20 0.30
▸ CCNE1 P24864 1/20 0.30
▸ CDK2 P24941 1/20 0.30
▸ CDK8 P49336 1/20 0.30
▸ CDK7 P50613 1/20 0.30
▸ CCNH P51946 1/20 0.30
▸ CCNA1 P78396 1/20 0.30
▸ CDK3 Q00526 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24418626 0.71 CCNT1 (0.54) CCNT1CDK9PDE2ACDK1CDK4
SCHEMBL24418567 0.70 CCNT1 (0.56) CCNT1CDK9CDK1CDK4CCNA2
SCHEMBL31441660 0.69 CHRNA7 (0.35) PIM1SMPD3IRAK4CHRNA7HTR3A
SCHEMBL13500742 0.69 ALDH1A1 (0.39) IRAK4PDE2A
SCHEMBL31069505 0.69 DYRK1A (0.41) CCNT1CDK9IRAK4CDK1CDK4
SCHEMBL23777305 0.69 CCNT1 (0.30) CCNT1CDK9CDK1CDK4CCNA2
SCHEMBL24422759 0.67 SMPD3 (0.34) CCNT1CDK9SMPD3IRAK4PDE2A
SCHEMBL31465374 0.64 ACVR2A (0.36) —
SCHEMBL29339727 0.62 SMPD3 (0.57) PIM1SMPD3
SCHEMBL17132579 0.62 SMPD3 (0.38) SMPD3IRAK4PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4240422-A1 COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY Kronos Bio, Inc. (US) 2023-09-13 — — EP disclosed
WO-2022098843-A1 COMPOUNDS AND METHODS FOR MODULATING CDK9 ACTIVITY Kronos Bio, Inc. (US) 2022-05-12 — — WO disclosed
Send feedback